Rafael Holdings Inc (NYSE:RFL) Share Price

Company Profile

Business description
Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.
Contact
520 Broad Street
NewarkNJ07102
USA
T: +1 212 658-1450
E: [email protected]
https://www.rafaelholdings.com
Sector
Real Estate
Stock type
Cyclical
Industry
Real Estate Services
Fiscal Year End
31 July 2026
Employees
23

Recommended

We believe a competitive—if not leading—AI feature suite will reinforce Apple’s wide-moat mobile device ecosystem.

William Kerwin, CFA | 12 January 2026

The shares are overvalued as investors are overly excited about defence and gold exposure.

Esther Holloway | 12 January 2026

Our view on the potential for additional offers.

Esther Holloway | 11 January 2026

Index	Last price	Change	% Change
All Ordinaries	9,171.30	44.20	0.48%
CAC 40	8,358.76	3.33	-0.04%
DAX 40	25,405.34	143.70	0.57%
Dow JONES (US)	49,590.20	86.13	0.17%
FTSE 100	10,140.70	16.10	0.16%
HKSE	27,082.79	474.31	1.78%
NASDAQ	23,733.90	62.56	0.26%
Nikkei 225	53,652.38	1,712.49	3.30%
NZX 50 Index	13,634.20	49.09	-0.36%
S&P 500	6,977.27	10.99	0.16%
S&P/ASX 200	8,840.70	49.40	0.56%
SSE Composite Index	4,174.30	9.02	0.22%